Search results for: 'OX40'

  • OX40 Screening Services Tumor necrosis factor receptor superfamily member 4, or OX40, is an immune co-stimulatory receptor. When OX40 is bound to its ligand, OX40L, signals are transmitted that serve to enhance survival of immune cells and increase pro-inflammatory signaling.  OX40 has been linked to different types of autoimmune and inflammatory diseases. OX40 is also a promising immunotherapy target because stimulation of OX40 has been implicated as a potential treat...
  • Methods For Drug Discovery   Immunotherapies  based on targeting the  PD-1:PD-L1  immune checkpoint pathway are having clinical impact and are giving new hope to cancer patients. However, positive response to treatment is not guaranteed and resistance remains a concern. Improving outcomes based on immunotherapy requires multiple approaches for manipulating the complexities of the immune system and tumor microenvironment. To meet these challenges, a series of r...
  • Immunotherapy Biochemical Screening Services Immunotherapy is a type of medical treatment that engages the body's immune system to fight diseases, such as cancer, infections, and autoimmune disorders. It works by either stimulating the immune system to attack cancer cells or other disease-causing agents, or by using synthetic proteins or antibodies to target specific molecules on the surface of cancer cells or other pathogens. Immunotherapy has shown prom...
  • CAR T-Cell Therapy Overview CAR-T is a cross of immunotherapy, gene therapy, and cellular therapy. Many successful immunotherapies are based on checkpoint inhibitors that block the mechanisms tumor cells use to hide from T cells. CAR-T immunotherapies go one step further by engineering T cells to enhance the immune response against a specific tumor antigen. CAR-T is a promising approach for cancer and other diseases, especially severe cancers that do not respond well to othe...
  • Combining Therapies for Targeting Immune Checkpoints   |  IMMUNE CHECKPOINTS  |           |  KINASES  |                |  PARPS  |              |  HDACS  |               |  CAR T-CELL THERAPY  | Cancer is a balance between the defens...
  • Citations   This page contains a list of scientific journal articles that have cited BPS products and services since 2013. We would like to congratulate all our loyal customers on their contributions to the scientific community. Our customers are truly amazing and dedicated scientists and this is evidenced by the outstanding research they are doing.  Search By Product Name or Catalog Number Name Title 10X HAT Assay Buffer (50095...